Elaborate measures for donor selection and the production of clotting factor concentrates have led to a high safety standard of these products...
Keywords: Plasmapräparate, Pharmakovigilanz, Inaktivierungsverfahren, Spenderselektion
01/2006 | Hämostaseologie, Schattauer